US: MITOTIX BOUGHT BY GERMAN GPC

Article Abstract:

Mitotix Inc., a Cambridge, Massachusetts-based cancer research firm, is being acquired by German Munich-based biotech company GPC AG. The deal takes place within a share swap, creating a company called GPC Biotech AG in Munich.

GPC AG, Mitotix Inc.

---

GERMANY/US: CANCER R&D DEAL BY COLEY, LUDWIG

Article Abstract:

German Hilden-based Ludwig Institut fur Krebsforschung has signed a cooperation agreement with Coley Pharmaceuticals Group of Wellesley, Massachusetts, on the development of new cancer treatments on the basis of CpG DNA molecules.

---

US: ROCHE INVESTS IN CANCER RESEARCH

Article Abstract:

Roche is injecting more than US$ 40mn in Tri-Path Imaging, a Burlington, North Carolina-based roducer of equipment and materials for cancer cell analysis. The Switzerland pharmaceutical maker thus raises its stake in Tri-Path to 26% and secures an option to raise it further to 36%.

Switzerland, Medical Instruments and Supplies, Medical Instruments & Equipment, Medical Equipment and Supplies Manufacturing, Medical equipment, Roche Holding AG

Similar abstracts:

• Abstracts: SWITZERLAND/UK: ROCHE/VERNALIS DEVELOPING TOGETHER. SWITZERLAND/US: CANCER R&D DEAL BY ROCHE, BMS. SWITZERLAND/UK: LONZA, CELLTECH COOPERATE

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.